1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	489_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	489_QUEST_clinical_caseMIR	SENT1	-	-
3	17	17		-	-	9-11	489_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	489_QUEST_clinical_caseMIR	SENT1	-	-
5	que	que	PR0CN000	-	-	17-20	489_QUEST_clinical_caseMIR	SENT1	-	-
6	presenta	presentar	VMIP3S0	-	-	21-29	489_QUEST_clinical_caseMIR	SENT1	-	-
7	desde	desde	SPS00	-	-	30-35	489_QUEST_clinical_caseMIR	SENT1	-	-
8	la	el	DA0FS0	-	-	36-38	489_QUEST_clinical_caseMIR	SENT1	-	-
9	primera	1	AO0FS0	-	-	39-46	489_QUEST_clinical_caseMIR	SENT1	-	-
10	menstruación	menstruación	NCFS000	C0025344#C0227854	entidad_observable#sustancia	47-59	489_QUEST_clinical_caseMIR	SENT1	-	-
11	reglas	regla	NCFP000	C0522637	objeto_físico	60-66	489_QUEST_clinical_caseMIR	SENT1	-	-
12	muy	muy	RG	C0442824	calificador	67-70	489_QUEST_clinical_caseMIR	SENT1	-	-
13	abundantes	abundante	AQ0CP0	-	-	71-81	489_QUEST_clinical_caseMIR	SENT1	-	-
14	.	.	Fp	-	-	81-82	489_QUEST_clinical_caseMIR	SENT1	-	-

1	Refiere	referir	VMIP3S0	-	-	83-90	489_QUEST_clinical_caseMIR	SENT2	-	-
2	epistaxis	epistaxis	NCFN000	C0014591	trastorno	91-100	489_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
3	frecuentes	frecuente	AQ0CP0	C0332183	calificador	101-111	489_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
4	.	.	Fp	-	-	111-112	489_QUEST_clinical_caseMIR	SENT2	-	-

1	Hematimetría	hematimetría	NCFS000	-	-	113-125	489_QUEST_clinical_caseMIR	SENT3	-	-
2	.	.	Fp	-	-	125-126	489_QUEST_clinical_caseMIR	SENT3	-	-

1	Hb	hb	NC00YL0	-	-	127-129	489_QUEST_clinical_caseMIR	SENT4	-	-
2	10,5	10.5	Z	-	-	130-134	489_QUEST_clinical_caseMIR	SENT4	-	-
3	g	g	NCMN000	-	-	135-136	489_QUEST_clinical_caseMIR	SENT4	-	-
4	/	/	Fh	-	-	136-137	489_QUEST_clinical_caseMIR	SENT4	-	-
5	dL	decilitro	NCMN000	C0439241	calificador	137-139	489_QUEST_clinical_caseMIR	SENT4	-	-
6	,	,	Fc	-	-	139-140	489_QUEST_clinical_caseMIR	SENT4	-	-
7	VCM	vcm	NC00SC0	C0524587	entidad_observable	141-144	489_QUEST_clinical_caseMIR	SENT4	-	-
8	77	77		-	-	145-147	489_QUEST_clinical_caseMIR	SENT4	-	-
9	fL	fl	NC00SC0	C0475213	calificador	148-150	489_QUEST_clinical_caseMIR	SENT4	-	-
10	,	,	Fc	-	-	150-151	489_QUEST_clinical_caseMIR	SENT4	-	-
11	leucocitos	leucocito	NCMP000	C0023516	célula	152-162	489_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
12	7.200/μL	7.200/μL		-	-	163-171	489_QUEST_clinical_caseMIR	SENT4	-	-
13	con	con	SPS00	C0332287	atributo	172-175	489_QUEST_clinical_caseMIR	SENT4	-	-
14	fórmula	fórmula	NCFS000	-	-	176-183	489_QUEST_clinical_caseMIR	SENT4	-	-
15	normal	normal	AQ0CS0	C0205307	calificador	184-190	489_QUEST_clinical_caseMIR	SENT4	-	-
16	,	,	Fc	-	-	190-191	489_QUEST_clinical_caseMIR	SENT4	-	-
17	plaquetas	plaqueta	NCFP000	C0005821	estructura_corporal	192-201	489_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
18	182.000/_x001F_L	182.000/_x001F_L		-	-	202-218	489_QUEST_clinical_caseMIR	SENT4	-	-
19	.	.	Fp	-	-	218-219	489_QUEST_clinical_caseMIR	SENT4	-	-

1	Tiempo	tiempo	NCMS000	C0033707_1	procedimiento_1	220-226	489_QUEST_clinical_caseMIR	SENT5	-	-
2	de	de	SPS00	C0033707_2	procedimiento_2	227-229	489_QUEST_clinical_caseMIR	SENT5	-	-
3	protrombina	protrombina	NCFS000	C0033707_3	procedimiento_3	230-241	489_QUEST_clinical_caseMIR	SENT5	-	-
4	12	12		-	-	242-244	489_QUEST_clinical_caseMIR	SENT5	-	-
5	"	"	Fe	-	-	244-245	489_QUEST_clinical_caseMIR	SENT5	-	-
6	(	(	Fpa	-	-	246-247	489_QUEST_clinical_caseMIR	SENT5	-	-
7	12	12		-	-	247-249	489_QUEST_clinical_caseMIR	SENT5	-	-
8	"	"	Fe	-	-	249-250	489_QUEST_clinical_caseMIR	SENT5	-	-
9	)	)	Fpt	-	-	250-251	489_QUEST_clinical_caseMIR	SENT5	-	-
10	,	,	Fc	-	-	251-252	489_QUEST_clinical_caseMIR	SENT5	-	-
11	TTPa	tiempo_de_tromboplastina_parcial_activado	NC00YL0	-	-	253-257	489_QUEST_clinical_caseMIR	SENT5	-	-
12	34	34		-	-	258-260	489_QUEST_clinical_caseMIR	SENT5	-	-
13	"	"	Fe	-	-	260-261	489_QUEST_clinical_caseMIR	SENT5	-	-
14	(	(	Fpa	-	-	262-263	489_QUEST_clinical_caseMIR	SENT5	-	-
15	30	30		-	-	263-265	489_QUEST_clinical_caseMIR	SENT5	-	-
16	"	"	Fe	-	-	265-266	489_QUEST_clinical_caseMIR	SENT5	-	-
17	)	)	Fpt	-	-	266-267	489_QUEST_clinical_caseMIR	SENT5	-	-
18	,	,	Fc	-	-	267-268	489_QUEST_clinical_caseMIR	SENT5	-	-
19	fibrinógeno	fibrinógeno	NCMS000	C0016006	sustancia	269-280	489_QUEST_clinical_caseMIR	SENT5	-	-
20	340	340	Z	-	-	281-284	489_QUEST_clinical_caseMIR	SENT5	-	-
21	mg	mg	NCMN000	-	-	285-287	489_QUEST_clinical_caseMIR	SENT5	-	-
22	/	/	Fh	-	-	287-288	489_QUEST_clinical_caseMIR	SENT5	-	-
23	dL	decilitro	NCMN000	C0439241	calificador	288-290	489_QUEST_clinical_caseMIR	SENT5	-	-
24	.	.	Fp	-	-	290-291	489_QUEST_clinical_caseMIR	SENT5	-	-

1	Agregación	agregación	NCFS000	C0032176_1	calificador_1	292-302	489_QUEST_clinical_caseMIR	SENT6	-	-
2	plaquetaria	plaquetario	AQ0FS0	C0032176_2	calificador_2	303-314	489_QUEST_clinical_caseMIR	SENT6	-	-
3	con	con	SPS00	C0332287	atributo	315-318	489_QUEST_clinical_caseMIR	SENT6	-	-
4	ADP	adp	NC00YL0	-	-	319-322	489_QUEST_clinical_caseMIR	SENT6	-	-
5	,	,	Fc	-	-	322-323	489_QUEST_clinical_caseMIR	SENT6	-	-
6	colágeno	colágeno	NCMS000	C0009325	sustancia	324-332	489_QUEST_clinical_caseMIR	SENT6	-	-
7	y	y	CC	C1706368	calificador	333-334	489_QUEST_clinical_caseMIR	SENT6	-	-
8	epinefrina	epinefrina	NCFS000	C0014563	producto#sustancia	335-345	489_QUEST_clinical_caseMIR	SENT6	B-Grp_Medicamento	-
9	.	.	Fp	-	-	345-346	489_QUEST_clinical_caseMIR	SENT6	-	-
10	ausencia	ausencia	NCFS000	C0332197_1	calificador_1	347-355	489_QUEST_clinical_caseMIR	SENT6	-	-
11	de	de	SPS00	C0332197_2	calificador_2	356-358	489_QUEST_clinical_caseMIR	SENT6	-	-
12	respuesta	respuesta	NCFS000	-	-	359-368	489_QUEST_clinical_caseMIR	SENT6	-	-
13	.	.	Fp	-	-	368-369	489_QUEST_clinical_caseMIR	SENT6	-	-

1	Aglutina	aglutinar	VMIP3S0	-	-	370-378	489_QUEST_clinical_caseMIR	SENT7	-	-
2	con	con	SPS00	C0332287	atributo	379-382	489_QUEST_clinical_caseMIR	SENT7	-	-
3	ristocetina	ristocetina	NCFS000	C0035654	producto#sustancia	383-394	489_QUEST_clinical_caseMIR	SENT7	B-Grp_Medicamento	-
4	.	.	Fp	-	-	394-395	489_QUEST_clinical_caseMIR	SENT7	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	396-398	489_QUEST_clinical_caseMIR	SENT8	-	-
2	citometría	citometría	NCFS000	-	-	399-409	489_QUEST_clinical_caseMIR	SENT8	-	-
3	se	se	P00CN000	-	-	410-412	489_QUEST_clinical_caseMIR	SENT8	-	-
4	observa	observar	VMIP3S0	-	-	413-420	489_QUEST_clinical_caseMIR	SENT8	-	-
5	ausencia	ausencia	NCFS000	C0332197_1	calificador_1	421-429	489_QUEST_clinical_caseMIR	SENT8	-	-
6	de	de	SPS00	C0332197_2	calificador_2	430-432	489_QUEST_clinical_caseMIR	SENT8	-	-
7	Gp	gp	NC00YL0	-	-	433-435	489_QUEST_clinical_caseMIR	SENT8	B-Grp_Enfermedad	-
8	IIb-IIIa	iib-iiia	AQ0FS00	-	-	436-444	489_QUEST_clinical_caseMIR	SENT8	I-Grp_Enfermedad	-
9	.	.	Fp	-	-	444-445	489_QUEST_clinical_caseMIR	SENT8	-	-

1	Cuál	cuál	PT0CS000	-	-	446-450	489_QUEST_clinical_caseMIR	SENT9	-	-
2	es	ser	VSIP3S0	-	-	451-453	489_QUEST_clinical_caseMIR	SENT9	-	-
3	el	el	DA0MS0	-	-	454-456	489_QUEST_clinical_caseMIR	SENT9	-	-
4	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	457-468	489_QUEST_clinical_caseMIR	SENT9	-	-
5	.	.	Fp	-	-	468-469	489_QUEST_clinical_caseMIR	SENT9	-	-

